Skip to search formSkip to main contentSkip to account menu

Parlodel

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

2-Bromoergocryptine MesylateBromocriptine
Bromocriptine 2.5 MG Oral Tablet [Parlodel]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine
We used Neuromolecular Imaging (NMI) and trademarked BRODERICK PROBE® mini-implantable biosensors, to selectively and separately… 
2004
2004
Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone
SummaryThe pharmacokinetics and endocrine actions of a long-acting form of bromocriptine (Parlodel) were examined in a controlled… 
1999
1999
Effects of Parlodel on sleep-wake cycles in rats with MPTP-induced depressive syndrome
Chronic treatment with Parlodel normalized the parameters of REM sleep disturbed by multiple systemic administration of the… 
1998
1998
[Postpartum myocardial infarction induced by Parlodel].
The authors report the case of a 28 year old woman who developed antero-septoapical myocardial infarction in the post-partum… 
Review
1996
Review
1996
Convulsions, hypertension crisis and acute renal failure in postpartum: role of bromocriptine?
Prof. A. Fournier, Service de Néphrologie, Hôpital Sud, F-80054 Amiens Cedex 1 (France) Dear Sir, Bromocriptine mesylate… 
1992
1992
Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO.
In this study, we compared in an intent-to-treat analysis the tolerance and efficacy of Parlodel SRO with its standard galenic… 
1987
1987
A Comparison of Bromocriptine (Parlodel®) and Levodopa-Carbidopa (Sinemet®) For Treatment of “De Novo” Parkinson's Disease Patients
ABSTRACT: Fifty-one patients were enrolled in a double-blind, parallel group, multicentre study conducted to assess short-term… 
1986
1986
Parlodel treatment of uremic hypogonadism in men.
Parlodel, 2.5 mg daily, was given during 1-3 months to 14 uremic hypogonadal patients (placebo controlled in 6). Except for a… 
Review
1984
Review
1984
Surveillance of Parlodel (bromocriptine) in pregnancy and offspring
Hyperprolactinaemic conditions often lead to infertility, particularly in female patients. Before the therapeutic potential of… 
1982
1982
Bromocriptine (parlodelR) in the treatment of parkinson's disease
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)